Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for Apoptosis Induction in FAP
NCT00503035Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 2003
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib oral solution in familial adenomatous polyposis (FAP), sponsored by University of Texas MD Anderson Cancer Center. Started Aug 2003; status: completed.
02
Drugs
celecoxib oral solution
03
Conditions
familial adenomatous polyposis (FAP)
Beyond the preview
Go deeper on NCT00503035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00503035.